Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
adolescentsadultsmalariaplasmodium-falciparum
malaria infection, plasmodium falciparum, chemoprevention, malaria, plasmodium eukaryotic translation elongation factor 2 (peef2), exposure response, adults, adolescents, asymptomatic infection, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 894050
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.